SCHEMBL874936

SCHEMBL874936

O=C(NO)c1ccc(I)cc1Nc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.47
GFER P55789 1/20 0.47
NGLY1 Q96IV0 1/20 0.47
AKR1C3 P42330 2/20 0.46
AKR1C2 P52895 2/20 0.46
HDAC6 Q9UBN7 4/20 0.43
HDAC1 Q13547 4/20 0.43
HDAC2 Q92769 3/20 0.43
HDAC8 Q9BY41 3/20 0.43
HDAC7 Q8WUI4 2/20 0.43
HDAC3 O15379 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC10 Q969S8 1/20 0.43
HDAC11 Q96DB2 1/20 0.43
HDAC9 Q9UKV0 1/20 0.43
HDAC5 Q9UQL6 1/20 0.43
FABP4 P15090 1/20 0.42
GPR27 Q9NS67 1/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3422677 0.85 AKR1C3 (0.60) MAPTGFERNGLY1AKR1C3AKR1C2
SCHEMBL25060927 0.84 MAPT (0.50) MAPTGFERNGLY1AKR1C3AKR1C2
SCHEMBL874935 0.81 MEN1 (0.51) MAPTAKR1C3AKR1C2HDAC6HDAC1
SCHEMBL27716600 0.80 MAPT (0.67) MAPTGFERNGLY1AKR1C3AKR1C2
SCHEMBL976886 0.80 FABP4 (0.65) MAPTAKR1C3AKR1C2HDAC6HDAC1
SCHEMBL14392471 0.72 MAP2K1 (0.51) MAPTGFERNGLY1AKR1C3AKR1C2
SCHEMBL7752024 0.71 KDM4E (0.53) GFERHDAC6HDAC8HDAC7MPO
SCHEMBL5391631 0.71 MAP2K1 (0.53)
SCHEMBL351705 0.70 MAPT (0.79) MAPTGFERNGLY1AKR1C3AKR1C2
SCHEMBL5396108 0.70 MAP2K1 (0.41) MEN1KMT2ARXFP1ALOX15KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100292181-A1 COMPOSITIONS AND METHODS FOR DETECTING AND TREATING HIV INFECTIONS GEORGE MASON INTELLECTUAL PROPERTIES, INC. 2010-11-18 US claimed
EP-2236620-A2 Compositions and methods for detecting and treating HIV infection George Mason Intellectual Properties, Inc. (US) 2010-10-06 EP claimed
EP-2021496-A2 COMPOSITIONS AND METHODS FOR DETECTING AND TREATING HIV INFECTION George Mason Intellectual Properties, Inc. (US) 2009-02-11 EP claimed
US-20080064026-A1 COMPOSITIONS AND METHODS FOR DETECTING AND TREATING HIV INFECTIONS CENTER FOR APPLIED PROTEOMICS & MOLECULAR MEDICINE 2008-03-13 US claimed
WO-2007130523-A2 COMPOSITIONS AND METHODS FOR DETECTING AND TREATING HIV INFECTION GEORGE MASON INTELLECTUAL PROPERTIES, INC. (US) 2007-11-15 WO claimed
EP-1301472-B1 OXYGENATED ESTERS OF 4-IODO PHENYLAMINO BENZHYDROXAMIC ACIDS WARNER LAMBERT CO (US) 2014-03-26 EP disclosed
WO-2012040579-A2 MOLECULAR SCREENING ACROSS DEFINED STIFFNESS MATRICES PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2012-03-29 WO disclosed
US-20100292181-A1 COMPOSITIONS AND METHODS FOR DETECTING AND TREATING HIV INFECTIONS GEORGE MASON INTELLECTUAL PROPERTIES, INC. 2010-11-18 US disclosed
EP-2236620-A2 Compositions and methods for detecting and treating HIV infection George Mason Intellectual Properties, Inc. (US) 2010-10-06 EP disclosed
US-7662547-B2 Compositions and methods for detecting and treating HIV infections GEORGE MASON INTELLECTUAL PROPERTIES, INC. (US) 2010-02-16 US disclosed
EP-2021496-A2 COMPOSITIONS AND METHODS FOR DETECTING AND TREATING HIV INFECTION George Mason Intellectual Properties, Inc. (US) 2009-02-11 EP disclosed
US-7411001-B2 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids WARNER-LAMBERT COMPANY (US) 2008-08-12 US disclosed
WO-2000040237-A1 ANTIVIRAL METHOD USING MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 2000-07-13 WO disclosed
WO-2000040235-A2 TREATMENT OF ASTHMA WITH MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 2000-07-13 WO disclosed
WO-2000037141-A1 COMBINATION CHEMOTHERAPY WARNER-LAMBERT COMPANY (US) 2000-06-29 WO disclosed
WO-2000035435-A1 USE OF A MEK INHIBITOR FOR PREVENTING TRANSPLANT REJECTION WARNER-LAMBERT COMPANY (US) 2000-06-22 WO disclosed
WO-2000035436-A2 TREATMENT OF ARTHRITIS WITH MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 2000-06-22 WO disclosed
EP-0993439-A1 4-BROMO OR 4-IODO PHENYLAMINO BENZHYDROXAMIC ACID DERIVATIVES AND THEIR USE AS MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 2000-04-19 EP disclosed
WO-1999001426-A1 4-BROMO OR 4-IODO PHENYLAMINO BENZHYDROXAMIC ACID DERIVATIVES AND THEIR USE AS MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 1999-01-14 WO disclosed
WO-1998037881-A1 METHOD OF TREATING OR PREVENTING SEPTIC SHOCK BY ADMINISTERING A MEK INHIBITOR WARNER LAMBERT COMPANY (US) 1998-09-03 WO disclosed